Stock listing
NASDAQ:SNTS Santarus Inc Stock
Follow Santarus Inc into a list and get an email when it puts out news.
Last close · NASDAQ:SNTS
$31.96 USD
Close on Dec 31, 2013 · No longer trades
- Lowest – highest close
- $1.18 – $32.18 USDSince Apr 1, 2004 · lowest Mar 16, 2009 · highest Nov 29, 2013
Delisted NASDAQ:SNTS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:SNTS
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Santarus Inc on 6ix
- Decks
- 8 decks · latest Jul 9, 2013
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (July 2013) | Investor deck | 32 slides | Jul 9, 2013 |
| Investor Day (April 2013) | Investor day | 114 slides | Apr 11, 2013 |
| Investor Presentation (June 2011) | Investor deck | 28 slides | Jun 22, 2011 |
| Technical Presentation (May 2011) | Technical | 24 slides | May 9, 2011 |
| Technical Presentation (May 2011) | Technical | 25 slides | May 9, 2011 |
| Investor Day (January 2011) | Investor day | 108 slides | Jan 20, 2011 |
| Investor Presentation (January 2006) | Investor deck | 28 slides | Jan 6, 2006 |
| Investor Presentation (September 2005) | Investor deck | 27 slides | Sep 27, 2005 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Wendall Wierenga Other companies: Crinetics Pharmaceuticals, Inc. (Director · Since at least Jul 17, 2018); Cytokinetics, Incorporated (Director · Since at least Feb 9, 2011); Concert Pharmaceuticals Inc (Director · Mar 13, 2014 – Jun 14, 2018 · Past); Apricus Biosciences Inc (Director · Mar 10, 2014 – Jan 4, 2018 · Past); Ocera Therapeutics Inc (Director · Dec 19, 2013 – Dec 11, 2017 · Past); XenoPort Inc (Director · May 7, 2009 – Jul 5, 2016 · Past); Onyx Pharmaceuticals Inc (Director · Dec 15, 2008 – Oct 1, 2013 · Past) | EVP, R&D · Jun 20, 2011 – Jan 2, 2014 · Past |
| David Hale Other companies: Dermata Therapeutics, Inc. (Lead Director · Since at least Aug 12, 2021); Oncternal Therapeutics Inc (Director · Jun 7, 2019 – Jun 20, 2024 · Past); Histogen Inc (Director · Jul 24, 2013 – Jun 27, 2019 · Past); Somaxon Pharmaceuticals Inc (Director · Apr 2, 2012 – Dec 31, 2012 · Past) | Director · Mar 21, 2012 – Jan 2, 2014 · Past |
| Michael E Herman Other companies: Senomyx Inc (Director · May 31, 2007 – May 11, 2017 · Past); Cerner Corp (Director · May 25, 2007 – May 27, 2010 · Past) | Director · Jun 14, 2007 – Jan 2, 2014 · Past |
| Mark Totoritis | SVP, Clinical Research · Mar 12, 2012 – Jan 2, 2014 · Past |
Log in to ask 6ix AI your own questions about Santarus Inc.